Shaanxi Kanghui Pharm Co LtdCompany expects to turn loss into profit with net profit of ~11 million yuan, driven by asset disposal gains and improved subsidiary profitability.

Kanghui Shares released its 2026 semi-annual performance forecast, expecting to achieve a net profit attributable to the parent of around 11 million yuan in the first half, turning loss into profit compared with the same period last year. The company gained non-recurring income of 43.29 million yuan from disposing of some idle assets, which had a significant positive impact on the current period's performance. The wholly-owned subsidiary Beijing Kanghui Zhichuang Technology Co., Ltd. achieved a net profit of about 3.46 million yuan, and the controlling subsidiary Jiangsu Huihe Shuneng Technology Co., Ltd. achieved a net profit of about 2.75 million yuan, both effectively improving the current profitability level.
Shaanxi Kanghui Pharm Co LtdCompany expects to turn loss into profit with net profit of ~11 million yuan, driven by asset disposal gains and improved subsidiary profitability.
Wholly-owned subsidiary achieved net profit of ~3.46 million yuan, contributing to parent's turnaround.
Controlling subsidiary achieved net profit of ~2.75 million yuan, improving overall profitability.